|
"liu tw"的相关文件
显示项目 111-139 / 139 (共3页)
<< < 1 2 3
每页显示[10|25|50]项目
| 國立臺灣大學 |
2008-03 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial.
|
Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ |
| 國家衛生研究院 |
2007-05 |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result
|
Liang, PC; Ch'ang, HJ; Hsu, C; Tseng, SS; Shih, TTF; Liu, TW |
| 國家衛生研究院 |
2007 |
A prospective comparative study of prophylactic or therapeutic use of lamivudine for chemotherapy-associated hepatitis B (HBV) reactivation in nowhodgkin's lymphoma (NHL) patients
|
Hsu, C;Hsiung, CA;Su, LJ;Hwang, WS;Wang, MC;Lin, SF;Lin, TH;Hsiao, HH;Young, JH;Chang, MC;Huang, MJ;Liao, YM;Li, CC;Wu, HB;Chao, TY;Liu, TW;Cheng, AL;Chen, PJ |
| 國家衛生研究院 |
2006-11 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah, HS; Chao, Y; Chen, LT; Yao, TJ; Huang, JD; Chang, JY; Chen, PJ; Chuang, TR; Chin, YH; Whang-Peng, J; Liu, TW |
| 國家衛生研究院 |
2006-07 |
Congruence of knowledge, experiences, and preferences for disclosure of diagnosis and prognosis between terminally-ill cancer patients and their family caregivers in Taiwan
|
Tang, ST; Liu, TW; Lai, MS; Liu, LN; Chen, CH; Koong, SL |
| 國立臺灣大學 |
2006-06 |
Controlled growth of aluminium nitride nanorod arrays via chemical vapour deposition
|
Yang J; Liu TW; Hsu CW; Chen LC; Chen KH; Chen CC |
| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-03 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-01 |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma
|
Wang, CC; Chang, JY; Liu, TW; Lin, CY; Yu, YC; Hong, RL |
| 國家衛生研究院 |
2005-12 |
Pulmonary embolism after transcatheter arterial chemoembolization
|
Shiah, HS; Liu, TW; Chen, LT; Chang, JY; Liu, JM; Chuang, TR; Lee, WS; Whang-Peng, J |
| 國家衛生研究院 |
2005-12 |
Concordance of preferences for end-of-life care between terminally ill cancer patients and their family caregivers in Taiwan
|
Tang, ST;Liu, TW;Lai, MS;Liu, LN;Chen, CH |
| 國家衛生研究院 |
2005-09 |
Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin
|
Chan, CH; Liu, TW; Chen, LT; Chang, JY; Whang-Peng, J |
| 國家衛生研究院 |
2005-08-01 |
alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma
|
Chen, LT; Liu, TW; Chao, Y; Shiah, HS; Chang, JY; Juang, SH; Chen, SC; Chuang, TR; Chin, YH; Whang-Peng, J |
| 國家衛生研究院 |
2005-07 |
erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+in immunohistochemical analysis
|
Lan, C; Liu, JM; Liu, TW; Hsu, DH; Liang, SC; Chen, JR; Whang-Peng, J |
| 國家衛生研究院 |
2005-05-20 |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
|
Chan, ATC; Hsu, MM; Goh, BC; Hui, EP; Liu, TW; Millward, MJ; Hong, RL; Whang-Peng, J; Ma, BBY; To, KF; Mueser, M; Amellal, N; Lin, X; Chang, AY |
| 高雄醫學大學 |
2005 |
Pulmonary embolism after transcatheter arterial chemoembolization
|
劉滄梧;陳立宗;彭汪嘉康 ; Shiah HS;Liu TW;Chen LT;Chang JY;Liu JM;Chuang TR;Lee WS;Whang-Peng J |
| 國家衛生研究院 |
2004-12 |
Prognostic implications of the expression of erbB2, topoisomerase II alpha and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy
|
Liu, JM; Chen, LT; Li, AFY; Wu, CW; Lan, C; Chung, TR; Shiah, HS; Lee, KD; Liu, TW; Whang-Peng, J |
| 國家衛生研究院 |
2004-09 |
Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: A preliminary study
|
Wang, J; Chen, LT; Tsang, YM; Liu, TW; Shih, TTF |
| 國家衛生研究院 |
2004-04 |
Effect of calcium channel blockers on vertebral bone marrow perfusion of the lumbar spine
|
Shih, TTF; Chang, CL; Tseng, WYI; Hsiao, LK; Shen, LC; Liu, TW; Yang, PC |
| 國家衛生研究院 |
2004 |
Hepatocellular carcinoma with intra-atrial tumor thrombi - A report of three cases responsive to thalidomide treatment and literature review
|
Chang, JY; Ka, WS; Chao, TY; Liu, TW; Chuang, TR; Chen, LT |
| 國家衛生研究院 |
2002-07-01 |
Novel mutation of topoisomerase I in rendering cells resistant to camptothecin
|
Chang, JY; Liu, JF; Juang, SH; Liu, TW; Chen, LT |
| 國家衛生研究院 |
2002-07 |
Non-surgical treatment for afferent loop syndrome in recurrent gastric cancer complicated by peritoneal carcinomatosis: percutaneous transhepatic duodenal drainage followed by 24-hour infusion of high-dose fluorouracil and leucovorin
|
Lee, KD; Liu, TW; Wu, CW; Tiu, CM; Liu, JM; Chung, TR; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2002-04-01 |
A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients
|
Chi, KH; Chang, YC; Guo, WY; Leung, MJ; Shiau, CY; Chen, SY; Wang, LW; Lai, YL; Hsu, MM; Lian, SL; Chang, CH; Liu, TW; Chin, YH; Yen, SH; Perng, CH; Chen, KY |
| 國家衛生研究院 |
2002 |
A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer
|
Chen, LT; Liu, TW; Wu, CW; Chung, TR; Shiah, HS; Jan, CM; Liu, JM; Whang-Peng, J; Chang, JY |
| 國家衛生研究院 |
2002 |
Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma
|
Chen, LT;Chao, Y;Yao, TJ;Huang, JD;Chang, JY;Chin, YH;Chuang, TR;Reed, E;Whang-Peng, J;Liu, TW |
| 國家衛生研究院 |
2000-06 |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Liu, TW; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2000-04 |
Adjuvant sequential chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil (ACMF) with concurrent radiotherapy in resectable advanced breast cancer
|
Hsieh, CI; Liu, MC; Cheng, SH; Liu, TW; Chen, CM; Chen, CMC; Tsou, MH; Huang, AT |
| 國家衛生研究院 |
1999-09 |
A multi-centre phase II trial of gemcitabine (GEM) and vinorelbine (VRL) in patients (PTS) with stage III-IV non small cell lung cancer (NSCLC)
|
Chen, YM;Perng, RP;Peng, JW;Liu, TW;Yang, KY;Lin, WC;Wu, HW;Shih, JF;Liu, JM;Chen, LT;Tsai, CM |
| 國家衛生研究院 |
1996-07-17 |
Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region
|
Liu, JM; Chen, YM; Chao, Y; Liu, TW; Chou, CM; Chen, LT; Yu, WL; WhangPeng, J |
显示项目 111-139 / 139 (共3页)
<< < 1 2 3
每页显示[10|25|50]项目
|
